Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Department of Justice
Daiichi Sankyo
Express Scripts
McKesson
Fish and Richardson
Farmers Insurance
McKinsey
Moodys

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088641

« Back to Dashboard

NDA 088641 describes GLUCAMIDE, which is a drug marketed by Ani Pharms Inc and is included in one NDA. Additional details are available on the GLUCAMIDE profile page.

The generic ingredient in GLUCAMIDE is chlorpropamide. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpropamide profile page.
Summary for 088641
Tradename:GLUCAMIDE
Applicant:Ani Pharms Inc
Ingredient:chlorpropamide
Patents:0
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 088641

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Oct 11, 1984TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Fuji
Accenture
Harvard Business School
Express Scripts
Healthtrust
Chinese Patent Office
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.